| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - | |
| Aug 23, 23 | Yang Xiaodong | Disposition | - |
Apexigen, Inc. (APGN) has recorded 67 insider transactions from 12 insiders. Total insider buying volume stands at $0, while total selling volume is $0. Insider activity shows a balanced mix of buying and selling.
Apexigen, Inc. (APGN) has recorded 67 insider operations, including 0 open-market purchases ($0), 0 sales ($0) and 67 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Apexigen, Inc. shows moderate insider activity with 5 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Yang Xiaodong (CEO), Duke William E. (CFO) & Hsu Frank J. (C SUITE), with respectively 16, 26, 8 transactions.
Across all 67 recorded transactions, the breakdown by type is: disposition (48, 72%), tax (12, 18%), grant (4, 6%), other (3, 4%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Apexigen, Inc. has recorded 67 insider operations in total, including 0 open-market purchases ($0), 0 sales ($0) and 67 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on August 23, 2023.
Insiders at Apexigen, Inc. show balanced activity with 50% purchases and 50% sales. Total buy volume is $0 versus $0 in sales.
InsiderLens tracks 12 insiders at Apexigen, Inc. (APGN). Yang Xiaodong (CEO, 16 tx), Duke William E. (CFO, 26 tx), Hsu Frank J. (C SUITE, 8 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for APGN is neutral, based on a 50% buy ratio across 0 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Apexigen, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.